latest news releases from the newsroom
Immunomedics Highlights Progress With Clinical Programs At R&D Day
MORRIS PLAINS, N.J., Sept. 17, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today provided a detailed review and update of the Company's clinical pipeline, including plans for future clinical and research developments at the Company's Research and Development Day held at the Waldorf Astoria Hotel in New York City. An archived version of today's webcast will be available through October 16, 2008 on the R&D Day page of the Investor Relations section of the Company's website at www.immunomedics.com.
Moderro Announces Web 2.0 Cloud Computer
NEW YORK, Sept. 17, 2008 (GLOBE NEWSWIRE) -- 2008 Web 2.0 Expo (Booth 1345) -- Moderro Technologies today announced the launch of Xpack Web 2.0 Cloud Computer -- first in a new generation of web thin clients.